Ovid Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2017 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ovid Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2017 to Q3 2024.
  • Ovid Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 71M shares, a 0.47% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 71M +329K +0.47% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 71M +369K +0.52% Aug 10, 2024 10-Q 2024-08-13
Q1 2024 70.7M +218K +0.31% Mar 5, 2024 10-K 2024-03-08
Q3 2023 70.7M +214K +0.3% Oct 31, 2023 10-Q 2023-11-03
Q2 2023 70.6M +183K +0.26% Aug 1, 2023 10-Q 2023-08-04
Q1 2023 70.5M +118K +0.17% Mar 10, 2023 10-K 2023-03-13
Q3 2022 70.5M +2.37M +3.49% Nov 4, 2022 10-Q 2022-11-08
Q2 2022 70.4M +2.49M +3.66% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 70.4M +4.62M +7.03% Mar 10, 2022 10-K 2022-03-15
Q3 2021 68.1M +4.66M +7.34% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 67.9M +10.8M +19% Aug 6, 2021 10-Q 2021-08-16
Q1 2021 65.8M +11M +20.2% Mar 8, 2021 10-K 2021-03-15
Q3 2020 63.4M +15.6M +32.7% Nov 5, 2020 10-Q 2020-11-13
Q2 2020 57.1M +18.4M +47.5% Aug 3, 2020 10-Q 2020-08-10
Q1 2020 54.7M +16M +41.4% Mar 4, 2020 10-K 2020-03-11
Q3 2019 47.8M +23.2M +93.9% Nov 6, 2019 10-Q 2019-11-08
Q2 2019 38.7M +14.1M +57.1% Jul 30, 2019 10-Q 2019-08-07
Q1 2019 38.7M +14.1M +57.2% Apr 29, 2019 10-Q 2019-05-07
Q3 2018 24.7M +50.8K +0.21% Nov 1, 2018 10-Q 2018-11-08
Q2 2018 24.6M +30K +0.12% Aug 2, 2018 10-Q 2018-08-09
Q1 2018 24.6M Mar 22, 2018 10-K 2018-03-29
Q3 2017 24.6M Nov 8, 2017 10-Q 2017-11-09
Q2 2017 24.6M Jun 13, 2017 10-Q 2017-06-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.